• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Postinterferon α-fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: cause or results?

作者信息

Toyoda Hidenori, Kumada Takashi, Tada Toshifumi

机构信息

Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.

出版信息

Hepatology. 2014 Aug;60(2):762-3. doi: 10.1002/hep.27064. Epub 2014 Jun 18.

DOI:10.1002/hep.27064
PMID:24519154
Abstract
摘要

相似文献

1
Postinterferon α-fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: cause or results?持续病毒学应答后干扰素α治疗后甲胎蛋白升高与肝细胞癌发生风险：原因还是结果？
Hepatology. 2014 Aug;60(2):762-3. doi: 10.1002/hep.27064. Epub 2014 Jun 18.
2
Could postinterferon treatment α-fetoprotein levels truly predict hepatocarcinogenesis?
Hepatology. 2014 Aug;60(2):763. doi: 10.1002/hep.27065. Epub 2014 Jun 26.
3
Reply: To PMID 23564522.
Hepatology. 2014 Aug;60(2):764. doi: 10.1002/hep.27066. Epub 2014 Jun 18.
4
α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C.干扰素治疗后甲胎蛋白水平与慢性丙型肝炎肝癌发生风险。
Hepatology. 2013 Oct;58(4):1253-62. doi: 10.1002/hep.26442. Epub 2013 Aug 19.
5
Development of hepatocellular carcinoma after sustained response to interferon therapy: how long should sustained responders with risk factors be followed?
J Gastroenterol. 2005 Feb;40(2):220-2. doi: 10.1007/s00535-005-1545-8.
6
The risk of hepatocellular carcinoma after sustained virological response in patients treated with the new direct-acting antiviral drugs: should we be worry about it?接受新型直接抗病毒药物治疗的患者实现持续病毒学应答后发生肝细胞癌的风险：我们应该为此担忧吗？
Expert Rev Anti Infect Ther. 2016 Nov;14(11):993-996. doi: 10.1080/14787210.2016.1243466.
7
Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.在日本，接受无干扰素治疗与基于干扰素治疗并实现持续病毒学应答的慢性丙型肝炎患者的背景特征差异，以及丙型肝炎病毒根除后发生肝细胞癌的风险。
J Viral Hepat. 2017 Jun;24(6):472-476. doi: 10.1111/jvh.12665. Epub 2017 Jan 11.
8
[Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].[干扰素治疗对丙型肝炎病毒阳性肝硬化患者肝细胞癌发生率的影响]
Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):600-4.
9
Post-treatment levels of α-fetoprotein predict incidence of hepatocellular carcinoma after interferon therapy.治疗后α-胎蛋白水平可预测干扰素治疗后肝细胞癌的发生。
Clin Gastroenterol Hepatol. 2014 Jul;12(7):1186-95. doi: 10.1016/j.cgh.2013.11.033. Epub 2013 Dec 7.
10
[Cost-effectiveness of antiviral therapy for chronic hepatitis C patients in prevention of hepatocellular cancer ].慢性丙型肝炎患者抗病毒治疗预防肝细胞癌的成本效益
Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):511-4.

引用本文的文献

1
Clinical Model for Predicting Hepatocellular Carcinomas in Patients with Post-Sustained Virologic Responses of Chronic Hepatitis C: A Case Control Study.预测慢性丙型肝炎持续病毒学应答患者肝细胞癌的临床模型：一项病例对照研究
Gut Liver. 2016 Nov 15;10(6):955-961. doi: 10.5009/gnl15321.